Literature DB >> 18704594

TGF-beta1 and IGF-1 and anastomotic recurrence of Crohn's disease after ileo-colonic resection.

Marco Scarpa1, Marina Bortolami, Susan L Morgan, Andromachi Kotsafti, Cesare Ruffolo, Renata D'Incà, Eugenia Bertin, Lino Polese, Davide F D'Amico, Giacomo C Sturniolo, Imerio Angriman.   

Abstract

BACKGROUND: After bowel resection, Crohn's disease (CD) recurs frequently in the site of the anastomosis. Alteration of normal healing processes may play a role in this phenomenon. Transforming growth factor beta (TGF-beta) and insulin-like growth factor (IGF-1) are involved in wound healing mechanisms with pro-fibrogenic properties. The aim of this study was to assess the expression of TGF-beta1 and insulin-like growth factor 1 (IGF-1) in the different zones of the bowel wall to understand why side-to-side anastomosis are associated to a lower recurrence rate compared to end-to-end ones. PATIENTS AND METHODS: Seventeen patients affected by CD who underwent ileo-colonic resection from 2004 to 2005 were enrolled in this study. Full-thickness tissue samples were obtained from the mesenteric, the lateral, and the anti-mesenteric sides of the macroscopically diseased and healthy ileum for each patient. TGF-beta1 and IGF-1 messenger RNAs (mRNAs) were quantified by real-time polymerase chain reaction. Myeloperoxidase activity and histological disease activity were assessed to quantify the ileal inflammation. Vimentin, desmin, and alpha-smooth muscle actin were stained with immunohistochemistry to assess the fibroblast, smooth muscle cell, and myofibroblasts populations. Comparisons and correlations were carried out with nonparametric tests.
RESULTS: In diseased ileum, TGF-beta1 mRNA transcripts in the antimesenteric side were significantly lower than those of the mesenteric side (p = 0.05), and a significant correlation between TGFbeta-1 levels in diseased bowel and the sampling site was observed (tau = 0.36, p = 0.03). On the contrary, neither the IGF-1 mRNA transcripts nor the distribution of fibroblast, smooth muscle cell, and myofibroblasts populations showed any relation with the sampling site.
CONCLUSION: TGF-beta1 mRNA expression was lower in the anti-mesenteric side of the diseased ileum, and this was consistent with the success of side-to-side anastomosis in preventing CD recurrence. Since high expression of TGF-beta1 was associated to early recurrence, it seems rationale to construct the anastomosis on the anti-mesenteric side of the bowel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704594     DOI: 10.1007/s11605-008-0641-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease.

Authors:  F F di Mola; H Friess; A Scheuren; P Di Sebastiano; H Graber; B Egger; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

Review 2.  Preventing postoperative recurrence of Crohn's disease.

Authors:  N R Borley; N J Mortensen; D P Jewell
Journal:  Br J Surg       Date:  1997-11       Impact factor: 6.939

3.  Operative and environmental risk factors for recurrence of Crohn's disease.

Authors:  D Moskovitz; R S McLeod; G R Greenberg; Z Cohen
Journal:  Int J Colorectal Dis       Date:  1999-11       Impact factor: 2.571

4.  Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.

Authors:  A Stallmach; D Schuppan; H H Riese; H Matthes; E O Riecken
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

5.  Suppression of macrophage function by suture materials and anastomotic recurrence of Crohn's disease.

Authors:  A D Scott; C Uff; R K Phillips
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

6.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Side-to-side stapled anastomosis may delay recurrence in Crohn's disease.

Authors:  M Hashemi; J R Novell; A A Lewis
Journal:  Dis Colon Rectum       Date:  1998-10       Impact factor: 4.585

9.  A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.

Authors:  Giovanni Monteleone; Jelena Mann; Ivan Monteleone; Piero Vavassori; Ronald Bremner; Massimo Fantini; Giovanna Del Vecchio Blanco; Roberto Tersigni; Luciano Alessandroni; Derek Mann; Francesco Pallone; Thomas T MacDonald
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

10.  Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.

Authors:  M W Babyatsky; G Rossiter; D K Podolsky
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  4 in total

Review 1.  Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.

Authors:  Michael F Cunningham; Neil G Docherty; J Calvin Coffey; John P Burke; P Ronan O'Connell
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

2.  Subclinical intestinal inflammation in patients with Crohn's disease following bowel resection: a smoldering fire.

Authors:  Cesare Ruffolo; Marco Scarpa; Diego Faggian; Daniela Basso; Renata D'Incà; Mario Plebani; Giacomo C Sturniolo; Nicolò Bassi; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

3.  Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis.

Authors:  C Severi; R Sferra; A Scirocco; A Vetuschi; N Pallotta; A Pronio; R Caronna; G Di Rocco; E Gaudio; E Corazziari; P Onori
Journal:  Eur J Histochem       Date:  2014-12-17       Impact factor: 3.188

Review 4.  Factors Promoting Development of Fibrosis in Crohn's Disease.

Authors:  Gerhard Rogler; Martin Hausmann
Journal:  Front Med (Lausanne)       Date:  2017-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.